首页|期刊导航|中国中西医结合急救杂志|黄芪甲苷通过SIRT1/AP-1信号轴调控软骨细胞氧化应激的机制研究

黄芪甲苷通过SIRT1/AP-1信号轴调控软骨细胞氧化应激的机制研究OA

Study on the mechanism of astragaloside Ⅳ regulating oxidative stress in chondrocytes via the sirtuin 1/activator protein-1 signaling axis

中文摘要英文摘要

目的 探讨黄芪甲苷(AS-Ⅳ)对白细胞介素-1β(IL-1β)诱导的 SW1353 细胞氧化损伤模型的保护作用及相关机制.方法 采用 100 μg/L IL-1β处理 SW1353 细胞 48 h 构建氧化损伤体外细胞模型,按随机数字表法分为空白对照组、模型组、AS-Ⅳ组、沉默信息调节因子 1(SIRT1)组、过表达激活蛋白-1(AP-1)组、SIRT1+AP-1 组;采用细胞增殖与毒性检测试剂盒 8(CCK-8)筛选 IL-1β最佳制模浓度和时间以及 AS-Ⅳ对骨关节炎(OA)治疗的最佳浓度和时间;运用慢病毒转染技术敲低 SIRT1、过表达 AP-1、敲低 SIRT1+过表达 AP-1;采用酶联免疫吸附试验(ELISA)检测各组细胞中丙二醛(MDA)、超氧化物歧化酶(SOD)、过氧化氢酶(CAT)及谷胱甘肽过氧化物酶(GSH-Px)含量;分别采用荧光定量反转录-聚合酶链反应(qRT-PCR)、蛋白质免疫印迹试验(Western blotting)检测 AP-1、SIRT1、凋亡相关蛋白 Bax 和 Bcl-2、天冬氨酸特异性半胱氨酸蛋白酶 3(caspase-3)的 mRNA 和蛋白表达水平.结果 模型组 CAT(kU/L:7.64±2.36 比 26.98±2.05)、SOD(kU/L:25.92±1.78 比 39.63±2.51)、GSH-Px(kU/L:176.70±8.36 比 261.40±12.71)含量均明显低于空白对照组(均 P<0.05),而 MDA 含量明显高于空白对照组(μmol/L:13.52±2.88 比 6.24±0.37,P<0.05).加入 AS-Ⅳ后,与模型组比较,AS-Ⅳ组 CAT(kU/L:24.82±2.49 比 7.64±2.36)、SOD(kU/L:38.56±2.25 比 25.92±1.78)、GSH-Px(kU/L:231.40±20.11 比 176.70±8.36)含量均明显升高(均 P<0.05),MDA 含量明显降低(μmol/L:7.12±1.00 比 13.52±2.88,P<0.05),且 AS-Ⅳ能有效抑制 SW1353 细胞凋亡,下调 AP-1 的蛋白表达(AP-1/Tubulin:0.39±0.03 比 1.11±0.06,P<0.05),同时上调 SIRT1 的蛋白表达(SIRT1/Tubulin:1.34±0.11 比1.06±0.12,P<0.05).在此基础上敲低 SIRT1,过表达 AP-1 以及敲低 SIRT1+过表达 AP-1 后,与 AS-Ⅳ组比较,SIRT1 组、AP-1 组及SIRT1+AP-1 组CAT(kU/L:5.32±1.22、5.93±2.11、4.13±1.93 比 24.82±2.49)、SOD(kU/L:25.19±1.18、26.02±2.04、21.02±1.56 比 38.56±2.25)、GSH-Px(kU/L:181.40±12.71、175.50±10.40、148.00±16.64 比 231.40±20.11)含量均明显降低(均 P<0.05),MDA 含量均增加(μmol/L:13.83±2.51、16.85±2.74、45.00±1.66 比 7.12±1.00,均 P<0.05),而 AP-1、Bax、caspase-3 的 mRNA 和蛋白表达水平均明显升高[AP-1 mRNA 表达(2-ΔΔCt):4.93±0.25、5.30±0.57、6.10±0.18 比 1.53±0.42,AP-1 蛋白表达(AP-1/Tubulin):1.11±0.04、1.18±0.10、1.60±0.09 比 0.39±0.03;Bax mRNA表达(2-ΔΔCt):4.60±0.43、4.76±0.63、6.16±0.53 比 1.49±0.45,Bax 蛋 白 表 达(Bax/Tubulin):0.80±0.11、0.92±0.06、1.48±0.10 比 0.43±0.08;caspase-3 mRNA 表达(2-ΔΔCt):7.27±0.90、7.12±1.09、9.38±0.58 比 1.20±0.35,caspase-3 蛋白表达(caspase-3/Tubulin):0.75±0.11、0.79±0.06、1.02±0.11 比 0.48±0.04,均P<0.05],SIRT1 和Bcl-2 的mRNA及蛋白表达水平均明显下降[SIRT1 mRNA表达(2-ΔΔCt):0.64±0.09、0.63±0.05、0.28±0.06 比 0.86±0.05,SIRT1 蛋白表达(SIRT1/Tubulin):0.94±0.05、0.97±0.07、0.26±0.06 比 1.34±0.11;Bcl-2 mRNA表达(2-ΔΔCt):0.38±0.04、0.43±0.05、0.18±0.08 比 0.70±0.09,Bcl-2 蛋白表达(Bcl-2/Tubulin):0.76±0.06、0.80±0.07、0.34±0.06 比1.15±0.08,均P<0.05].结论 AS-Ⅳ能够保护IL-1β诱导的SW1353细胞氧化损伤,改善SW1353细胞凋亡,其作用机制可能与其激活SIRT1/AP-1 信号通路有关.

Objective To explore the protective effect of astragalosideⅣ(AS-Ⅳ)on oxidative damage model induced by interleukin-1β(IL-1β)in SW1353 cells and its underlying mechanisms.Methods The SW1353 cells were treated with 100 μg/L IL-1β for 48 hours to construct an in vitro cell model of oxidative damage.The cells were randomly divided into six groups:blank control,model,AS-Ⅳ,sirtuin 1(SIRT1)-knockdown,activator protein-1(AP-1)-overexpression,and SIRT1-knockdown+AP-1-overexpression.The optimal concentration and time for IL-1β and the optimal concentration and time for AS-Ⅳ in the treatment of osteoarthritis(OA)were screened using the cell counting kit-8(CCK-8)assay.SIRT1 knockdown and AP-1 overexpression were achieved by lentiviral transfection.The contents of malondialdehyde(MDA),superoxide dismutase(SOD),catalase(CAT),and glutathione peroxidase(GSH-Px)in each group of cells were detected by enzyme-linked immunosorbent assay(ELISA).The mRNA and protein expressions of AP-1,SIRT1,Bax,Bcl-2,and caspase-3 were detected by quantitative reverse transcription-polymerase chain reaction(qRT-PCR)and Western blotting,respectively.Results The contents of CAT(kU/L:7.64±2.36 vs.26.98±2.05),SOD(kU/L:25.92±1.78 vs.39.63±2.51),and GSH-Px(kU/L:176.70±8.36 vs.261.40±12.71)in the model group were significantly lower than those in the blank control group(all P<0.05),while the content of MDA was significantly higher(μmol/L:13.52±2.88 vs.6.24±0.37,P<0.05).After the addition of AS-Ⅳ,compared with the model group,the contents of CAT(kU/L:24.82±2.49 vs.7.64±2.36),SOD(kU/L:38.56±2.25 vs.25.92±1.78),and GSH-Px(kU/L:231.40±20.11 vs.176.70±8.36)in the AS-Ⅳ group were significantly increased(both P<0.05),and the content of MDA(μmol/L:7.12±1.00 vs.13.52±2.88,P<0.05)was significantly decreased.Moreover,AS-Ⅳ could effectively inhibit the apoptosis of SW1353 cells,down-regulate the protein expression of AP-1(AP-1/Tubulin:0.39±0.03 vs.1.11±0.06,P<0.05),and up-regulate the protein expression of SIRT1(SIRT1/Tubulin:1.34±0.11 vs.1.06±0.12,P<0.05).After reducing SIRT1 knockdown,AP-1 overexpression,and combined SIRT1 knockdown with AP-1 overexpression,compared with the AS-Ⅳ group,the contents of CAT(kU/L:5.32±1.22,5.93±2.11,4.13±1.93 vs.24.82±2.49),SOD(kU/L:25.19±1.18,26.02±2.04,21.02±1.56 vs.38.56±2.25),and GSH-Px(kU/L:181.40±12.71,175.50±10.40,148.00±16.64 vs.231.40±20.11)in the SIRT1 group,AP-1 group,and SIRT1+AP-1 group were significantly decreased(all P<0.05),while the MDA content increased(μmol/L:13.83±2.51,16.85±2.74,45.00±1.66 vs.7.12±1.00,all P<0.05),and the mRNA and protein expression levels of AP-1,Bax,and caspase-3 were significantly increased[AP-1 mRNA expression(2-ΔΔCt):4.93±0.25,5.30±0.57,6.10±0.18 vs.1.53±0.42,AP-1 protein expression(AP-1/Tubulin):1.11±0.04,1.18±0.10,1.60±0.09 vs.0.39±0.03;Bax mRNA expression(2-ΔΔCt):4.60±0.43,4.76±0.63,6.16±0.53 vs.1.49±0.45,Bax protein expression(Bax/Tubulin):0.80±0.11,0.92±0.06,1.48±0.10 vs.0.43±0.08;caspase-3 mRNA expression(2-ΔΔCt):7.27±0.90,7.12±1.09,9.38±0.58 vs.1.20±0.35,caspase-3 protein expression(caspase-3/Tubulin):0.75±0.11,0.79±0.06,1.02±0.11 vs.0.48±0.04,all P<0.05],while the mRNA and protein expression levels of SIRT1 and Bcl-2 were significantly decreased(SIRT1 mRNA expression(2-ΔΔCt):0.64±0.09,0.63±0.05,0.28±0.06 vs.0.86±0.05,SIRT1 protein expression(SIRT1/Tubulin):0.94±0.05,0.97±0.07,0.26±0.06 vs.1.34±0.11;Bcl-2 mRNA expression(2-ΔΔCt):0.38±0.04,0.43±0.05,0.18±0.08 vs.0.70±0.09,Bcl-2 protein expression(Bcl-2/Tubulin):0.76±0.06,0.80±0.07,0.34±0.06 vs.1.15±0.08,all P<0.05).Conclusion AS-Ⅳ can protect SW1353 cells from oxidative damage induced by IL-1β and alleviate cell apoptosis,the mechanism of its action may be related to its activation of the SIRT1/AP-1 signaling pathway.

王桂宇;王建国;赖林;蒲萌;贾卓樾;刘琪

山西中医药大学基础医学院,国家中医药管理局基因表达调控实验室,山西 晋中 030619山西中医药大学基础医学院,国家中医药管理局基因表达调控实验室,山西 晋中 030619山西中医药大学基础医学院,国家中医药管理局基因表达调控实验室,山西 晋中 030619山西中医药大学基础医学院,国家中医药管理局基因表达调控实验室,山西 晋中 030619山西中医药大学基础医学院,国家中医药管理局基因表达调控实验室,山西 晋中 030619山西中医药大学基础医学院,国家中医药管理局基因表达调控实验室,山西 晋中 030619

黄芪甲苷氧化损伤凋亡沉默信息调节因子 1/激活蛋白-1 信号通路

Astragaloside ⅣOxidative damageApoptosisSirtuin 1/activator protein-1 signaling pathway

《中国中西医结合急救杂志》 2026 (2)

209-216,8

山西省中医药管理局山西中医药大学方药配伍及功用重点研究室开放课题(zyyyis2024023)山西中医药大学科技创新能力培育计划(2024PY-JL-9-01,2024PY-JL-9-02)山西中医药大学杏林英才计划项目(2025XJ01) The Open Research Project of the Key Laboratory of Formula and Function of Traditional Chinese Medicine,Shanxi University of Chinese Medicine and Shanxi Provincial Administration of Traditional Chinese Medicine(zyyyis2024023)Scientific and Technological Innovation Capacity Cultivation Program of Shanxi University of Chinese Medicine(2024PY-JL-9-01,2024PY-JL-9-02)Xinglin Talent Project of Shanxi University of Chinese Medicine(2025XJ01)

10.3969/j.issn.1008-9691.2026.02.014

评论